The plasmaMATCH trial: a multiple parallel cohort, open-label, multi-centre phase II clinical trial of ctDNA screening to direct targeted therapies in patients with advanced breast cancer (CRUK/15/010).
Authors
Turner, NBye, H
Kernaghan, S
Proszek, P
Fribbens, C
Moretti, L
Morden, J
Snowdon, C
Macpherson, I
Wardley, Andrew M
Roylance, R
Baird, R
Bliss, J
Ring, A
Affiliation
The Institute of Cancer Research, LondonIssue Date
2018-02-14
Metadata
Show full item recordCitation
The plasmaMATCH trial: a multiple parallel cohort, open-label, multi-centre phase II clinical trial of ctDNA screening to direct targeted therapies in patients with advanced breast cancer (CRUK/15/010) 2018, 78(4 Suppl): OT1-06-03 Cancer ResJournal
Cancer ResearchDOI
10.1158/1538-7445.SABCS17-OT1-06-03Type
Meetings and ProceedingsLanguage
enISSN
0008-54721538-7445
ae974a485f413a2113503eed53cd6c53
10.1158/1538-7445.SABCS17-OT1-06-03